$8.3Bn Coronavirus Response Act Lays Out US FDA’s, CDC’s And Localities’ Roles In Fighting Virus

An $8.3bn “Coronavirus Preparedness and Response Supplemental” funding act approved by the US Congress last week and signed into law on 6 March provides dollars and lays out the roles federal agencies, such as the FDA, and state and local agencies must play in containing and controlling the spread of COVID-19.

Financing of medicine and pharmaceuticals in connection with the coronavirus. Allocation of additional funds to fight the new virus. Increasing the profits of pharmaceutical companies.

More from Legislation

More from Policy & Regulation